Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children

J Infect Dis. 2003 Apr 1;187(7):1142-6. doi: 10.1086/368358. Epub 2003 Mar 13.

Abstract

Two-year-old children were vaccinated with 1 dose of meningococcal A/C conjugate (MACC) or meningococcal A/C polysaccharide (MACP) vaccine. Meningococcal serogroup A (MenA)-specific IgG geometric mean avidity indices (GMAIs) increased 1 month after vaccination with MACC (GMAI, 210; 95% confidence interval [CI], 140-300) and MACP (GMAI, 190; 95% CI, 120-310). One year after vaccination, the GMAI of the MACP-vaccinated cohort decreased to 130 (95%, CI 100-170), but a constant GMAI was maintained in the MACC-vaccinated cohort (210; 95% CI, 140-300), despite declining MenA-specific IgG antibody levels.

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Bacterial / analysis
  • Antibody Specificity
  • Cohort Studies
  • Female
  • Humans
  • Immunoglobulins / analysis
  • Infant
  • Male
  • Meningococcal Infections / immunology*
  • Meningococcal Infections / prevention & control
  • Meningococcal Vaccines / immunology*
  • Neisseria meningitidis
  • Time Factors
  • Vaccines, Conjugate / immunology*

Substances

  • Antibodies, Bacterial
  • Immunoglobulins
  • Meningococcal Vaccines
  • Vaccines, Conjugate